69 completed, 30 unknown, 10 terminated, 6 withdrawn. 24 Not applicable, 19 Phase 2, 15 Phase 3, 9 Phase 1, 6 Phase 4.
Follow SARS-CoV2 Infection: new trials by email Literature Review of SARS-CoV2 Infection trials Research Report on SARS-CoV2 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Respiratory Virus Transmission in Bangladeshi Classrooms Box Fan, UV Germicidal Irradiation Lamp Unit, Combined: Box Fan and UV Germicidal Irradiation Lamp Units - SARS-CoV2 Infection, Influenza Viral Infections | Not applicable | Withdrawn | Stanford University | 2025-10-01 | 2026-08-24 | |
| NAC for Attenuation of COVID-19 Symptomatology N-acetylcysteine, Placebo - Covid19, COVID-19 Pneumonia | Phase 2 | Unknown | Cambridge Health Alliance | 200 | 2024-03-31 | 2023-08-07 |
| Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection COVID-19/Flu A/Flu B/RSV Test Kit - SARS-CoV2 Infection, Influenza A | Unknown | EDAN Instruments Inc. | 1000 | 2023-12-10 | 2024-01-11 | |
| Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine PHH-1V81, Comirnaty Omicron XBB1.5 - SARS-CoV2 Infection | Phase 2 / Phase 3 | Completed | Hipra Scientific, S.L.U | 913 | 2023-11-15 | 2026-03-12 |
| PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway Nirmatrelvir/ritonavir, Placebo - Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection | Phase 3 | Active not recruiting | Haukeland University Hospital | 2000 | 2023-05-12 | 2025-11-21 |
| Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication - SARS-CoV2 Infection | Not applicable | Completed | Michigan State University | 264 | 2023-05-04 | 2025-01-17 |
| Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID stellate ganglion block with 0.5% bupivacaine - Post Acute COVID-19 Syndrome, Long COVID | Phase 1 | Completed | Jonathann Kuo, MD | 20 | 2023-01-03 | 2025-03-13 |
| International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response Fostamatinib, Placebo - COVID-19, SARS-CoV2 Infection | Phase 2 / Phase 3 | Terminated | NEAT ID Foundation | 28 | 2022-10-27 | 2025-05-02 |
| SARS-CoV-2 and Acetylsalicylic Acid (SARA) Low-dose acetylsalicylic acid, Placebo - SARS-CoV2 Infection, Covid19 | Phase 3 | Completed | Barcelona Institute for Global Health | 38 | 2022-09-14 | 2024-08-15 |
| Topical Antibacterial Agents for Prevention of COVID-19 Neosporin, Vaseline - COVID-19, SARS-CoV2 Infection | Phase 1 | Completed | Yale University | 67 | 2022-09-01 | 2023-10-03 |
| COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2 Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies - COVID-19, SARS-CoV2 Infection | Completed | University of Maryland, Baltimore | 56 | 2022-08-31 | 2023-05-10 | |
| Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs mRNA- COVID-19, Prevnar13 - SARS-CoV2 Infection, Coronavirus Infection | Phase 4 | Unknown | Mark Loeb | 414 | 2022-08-01 | 2022-06-30 |
| Qualitative and Functional Investigation of Lipids in Patients With SARS-CoV2 Infection - In Search of Atherogenic Sequelae Blood sample of 30 ml - SARS-CoV2 Infection | Completed | Centre Hospitalier Universitaire Dijon | 228 | 2022-06-14 | 2023-10-02 | |
| IMM-BCP-01 in Mild to Moderate COVID-19 IMM-BCP-01, Placebo - SARS-CoV2 Infection, COVID-19 | Phase 1 | Terminated | Immunome, Inc. | 9 | 2022-06-03 | 2024-09-26 |
| Washing COVID-19 Away With a Hypertonic Seawater Nasal Irrigation Solution Hypertonic seawater solution - SARS-CoV2 Infection | Not applicable | Completed | Larissa University Hospital | 56 | 2022-06-01 | 2023-11-03 |
| Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea Combination regimen: Fluoxetine, Prednisolone, Ivermectin, Combination regimen: Albendazole, Vitamin C - SARS-CoV2 Infection, COVID-19 | Phase 2 / Phase 3 | Withdrawn | Oriol Mitja | 2022-05-01 | 2023-03-09 | |
| A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine SCTV01C, Comirnaty - COVID-19, SARS-CoV2 Infection | Phase 2 | Withdrawn | Sinocelltech Ltd. | 2022-04-25 | 2024-02-09 | |
| PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19 Galactomannan, PLACEBO - COVID-19, COVID-19 Pandemic | Phase 3 | Unknown | Bioxytran Inc. | 408 | 2022-04-01 | 2022-03-09 |
| Awake Prone Positioning in Moderate to Severe COVID-19 a wake prone positioning - COVID-19, SARS-CoV2 Infection | Not applicable | Completed | Oxford University Clinical Research Unit, Vietnam | 93 | 2022-03-08 | 2023-06-07 |
| Outcomes of Neonates Born to Mothers With SARS-CoV-2 Infection in Shanghai SARS-CoV2 Infection, Neonatal Infection | Terminated | Children's Hospital of Fudan University | 236 | 2022-03-01 | 2023-12-29 |
Showing 20 of 119. Sign in to see all of them.
COVID-19 (119) · Coronavirus Infections (5) · Disease (5) · Cytokine Release Syndrome (4) · Acute Lung Injury (2) · Infections (2) · Pneumonia, Ventilator-Associated (2) · Respiratory Insufficiency (2) · Respiratory Tract Infections (2) · Severe Acute Respiratory Syndrome (2) · pediatric multisystem inflammatory disease, COVID-19 related (2) · Adenoviridae Infections (1) · Altitude Sickness (1) · Anosmia (1) · Anxiety Disorders (1)
Coronaviridae Infections (119) · Lung Diseases (119) · Nidovirales Infections (119) · Pneumonia (119) · RNA Virus Infections (119) · Respiratory Tract Diseases (119) · Pneumonia, Viral (118) · Virus Diseases (118) · Infections (117) · Respiratory Tract Infections (117) · Coronavirus Infections (114) · Pathological Conditions, Signs and Symptoms (22) · Pathologic Processes (17) · Disease Attributes (7) · Signs and Symptoms (7)
2019-nCoV Vaccine mRNA-1273 (3) · COVID-19 Vaccines (3) · Ivermectin (3) · BNT162 Vaccine (2) · Blood Specimen Collection (2) · ChAdOx1 nCoV-19 (2) · Sodium Chloride (2) · Tablets (2) · Acetaminophen (1) · Acetylcysteine (1) · Ad26COVS1 (1) · Ascorbic Acid (1) · Aspirin (1) · Atorvastatin (1) · BBV152 COVID-19 vaccine (1)
Assistance Publique - Hôpitaux de Paris (4) · Centre Hospitalier Universitaire de Nīmes (3) · The Hospital for Sick Children (3) · Ankara City Hospital Bilkent (2) · Barcelona Institute for Global Health (2) · Central Hospital, Nancy, France (2) · Collegium Medicum w Bydgoszczy (2) · Larissa University Hospital (2) · Michigan State University (2) · Rutgers, The State University of New Jersey (2) · A. Vogel AG (1) · AB Science (1) · ANRS, Emerging Infectious Diseases (1) · ARCTEC (1) · Association "Naso Sano" Onlus (1)
United States (30) · France (18) · Canada (9) · Spain (8) · Greece (6) · Italy (6) · Germany (5) · Denmark (4) · Poland (4) · Turkey (Türkiye) (4) · United Kingdom (4) · Belgium (3) · India (3) · Netherlands (3) · South Africa (3)
Ioannis Pantazopoulos, MD (2) · Akhtar Ashfaq, MD FACP FASN (1) · Alain Tremblay (1) · Alejandro Rodriguez Oviedo, MD,PhD,MsC (1) · Andrea Troxel, ScD (1) · Andy Peniket (1) · Anna Giuliano, PhD (1) · Anton Pozniak, Prof (1) · Bambang Darwono, Dr.Sp.OT (1) · Banu Cakir (1) · Brian A Roberts, MS, PMP (1)
PMID 17311621, PMID 19691668, PMID 20518086, PMID 23740695, PMID 32835303, PMID 32991844, PMID 33497610, PMID 33588914, PMID 33937733, PMID 34111590, PMID 34473343, PMID 34980198, PMID 35210504, PMID 35320289, PMID 35394449, PMID 35585684, PMID 35589363, PMID 35617826, PMID 35717995, PMID 35941669, PMID 36028897, PMID 36048877, PMID 36216961, PMID 36287578, PMID 36322537, PMID 36329227, PMID 36354032, PMID 36367144, PMID 36418127, PMID 36574985, PMID 36716763, PMID 37106321, PMID 37162923, PMID 37352211, PMID 37489818, PMID 37654668, PMID 37843910, PMID 38389078, PMID 38902860, PMID 38991216, PMID 39133923, PMID 39272117, PMID 39438096, PMID 39654551, PMID 39695262, PMID 40302048, PMID 40318849, PMID 41199272, PMID 41493514, PMID 41700320
U01CA260469 (2)